ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
6.10
0.37
(6.46%)
Closed March 29 04:00PM
5.9774
-0.1226
(-2.01%)
After Hours: 06:47PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
5.9774
Bid
-
Ask
-
Volume
4,748,066
5.65 Day's Range 6.16
4.44 52 Week Range 28.99
Market Cap
Previous Close
5.73
Open
5.73
Last Trade
21
@
6.15
Last Trade Time
Financial Volume
$ 28,416,849
VWAP
5.9849
Average Volume (3m)
6,326,113
Shares Outstanding
409,541,664
Dividend Yield
-
PE Ratio
-9.50
Earnings Per Share (EPS)
-0.64
Revenue
4.32B
Net Profit
-262.6M

About Agilon Health inc

Agilon Health Inc is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. The company enables physicians to create their own Medicare-centric globally capitated line of business. Agilon Health Inc is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. The company enables physicians to create their own Medicare-centric globally capitated line of business.

Sector
Health & Allied Services,nec
Industry
Health & Allied Services,nec
Headquarters
Wilmington, Delaware, USA
Founded
1970
Agilon Health inc is listed in the Health & Allied Services sector of the New York Stock Exchange with ticker AGL. The last closing price for Agilon Health was $5.73. Over the last year, Agilon Health shares have traded in a share price range of $ 4.44 to $ 28.99.

Agilon Health currently has 409,541,664 shares outstanding. The market capitalization of Agilon Health is $2.49 billion. Agilon Health has a price to earnings ratio (PE ratio) of -9.50.

AGL Latest News

agilon health, inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - AGL

agilon health, inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - AGL PR Newswire NEW YORK, March 26, 2024 NEW YORK, March 26, 2024...

Investor Alert: Investor Class Action Lawsuit Filed Against Agilon Health, Inc. (NYSE: AGL)

Investor Alert: Investor Class Action Lawsuit Filed Against Agilon Health, Inc. (NYSE: AGL) PR Newswire SAN DIEGO, March 22, 2024 SAN DIEGO, March 22, 2024 /PRNewswire/ -- DiCello Levitt LLP...

Investors in agilon health, inc. Should Contact The Gross Law Firm Before May 20, 2024 to Discuss Your Rights - AGL

Investors in agilon health, inc. Should Contact The Gross Law Firm Before May 20, 2024 to Discuss Your Rights - AGL PR Newswire NEW YORK, March 22, 2024 NEW YORK, March 22, 2024 /PRNewswire/...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

00018310972023falseFYP2Y11http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurren...

Form 8-K - Current report

0001831097FALSE00018310972024-02-272024-02-27UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549_____________________________________________FORM...

agilon health Reports Fourth Quarter 2023 Results

Revenue increased 72% to $1.06 billion in the fourth quarter 2023, Medicare Advantage membership increased 68% to 388,400, and total members on the agilon platform grew to 477,700 as of December...

AGL Credit Management Has Three CLOs Named Finalists for DealCatalyst's 2024 Deals of the Year Awards

AGL Credit Management Has Three CLOs Named Finalists for DealCatalyst's 2024 Deals of the Year Awards PR Newswire NEW YORK, Feb. 27, 2024 2 CLOs nominated for Best Performing BSL CLO Deal of the...

agilon health to Participate in the 44th Annual Cowen Health Care Conference

agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 44th Annual Cowen Health Care...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.47748.685.56.164.4456936355.16683992CS
4-0.4926-7.613601236486.476.524.4450066175.56314126CS
12-6.1526-50.722176422112.1312.184.4463261136.70773317CS
26-12.3926-67.461077844318.3720.374.4446259699.33114372CS
52-22.5626-79.056061667828.5428.994.44383825813.85351308CS
156-22.2726-78.841061946928.2544.834.44247453018.27498233CS
260-22.2726-78.841061946928.2544.834.44247453018.27498233CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 22.08
(364.84%)
31.9M
NXLNexalin Technologies Inc
$ 1.50
(92.31%)
11.67M
CEROCERo Therapeutics Holdings Inc
$ 3.112
(90.92%)
24.08M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
KYCHKeyarch Acquisition Corporation
$ 12.30
(75.58%)
196.62k
BOLDBoundless Bio Inc
 14.25
(-76.24%)
767.63k
PMECPrimech Holdings Ltd
$ 1.2999
(-66.50%)
8.28M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.1816
(-44.45%)
21.92M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
NBSTWNewbury Street Acquisition Corporation
$ 0.042279
(-38.28%)
1.75k
NKLANikola Corporation
$ 1.035
(13.85%)
163.84M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
MARAMarathon Digital Holdings Inc
$ 22.56
(2.22%)
86.14M
AKANAkanda Corporation
$ 0.1166
(-29.29%)
80.34M

Discussion

View Full Feed
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 5 minutes ago
Where is the MAA? Where is the NDA?

Positive peer review means zilch even if it ever happens.

Only filings for Approval will get AVXL to stop spiralling round the toilet.

Get it done already, Dr. M.
AVXL
newmedman newmedman 5 minutes ago
https://twitter.com/traecrowder/status/1773442173125726248
PennMilitia PennMilitia 7 minutes ago
You can say that again

Give me a break with some of these people.
FNMA
Letterpenny Letterpenny 8 minutes ago
Thanks bud. I’m glad you know where you stand. Wink wink. lol. Yes bud. Being honest with oneself is a good thing. I tend to always need a good smack to wake me up. My stench is just as bad as everyone else’s stench. I try to always keep in mind my limits bud. Unfortunately I also believe that no
sylvia07 sylvia07 8 minutes ago
Declaes, I agree with you!
GRST
sylvia07 sylvia07 8 minutes ago
Declaes, I agree with you!
GRST
knrorrel knrorrel 10 minutes ago
thx yeeees 100 pro agreement $BDPT looks great now , .005 soon back or pennyland
imho

BDPT
boi568 boi568 11 minutes ago
The merits of the trial results aren't affected, of course, by a change to FDA guidance. But that won't matter if a change to the FDA guidance changes the criteria for approval in Anavex's favor. All this is obvious: If the weak spot in the 2b/3 is the ADL outcome and if now the FDA is abandoning th
AVXL
janice shell janice shell 11 minutes ago
A very educational video. I am astonished that they survived!
knrorrel knrorrel 12 minutes ago
thx $BDPT looks great now , .005 soon back or pennyland
imho

BDPT
kevin 3 kevin 3 12 minutes ago
IF YOU WOULD LIKE TO PUT A LITTLE " WAGER " ON IT I WILL HAVE HIM POST HIS
(( T.D. - CHARLES SCHWAB ACC. V.X.I.T. SELL HISTORY )). AND " JBB4321 AND HUSSLER NONE OF THEM HAVE SOLD SHARES .
VXIT
knrorrel knrorrel 14 minutes ago
$NWPN wow thx , should moving hard https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174139311
imho

NWPN
knrorrel knrorrel 15 minutes ago
$NWPN wow thx , should moving hard https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174139311
imho

NWPN
newmedman newmedman 15 minutes ago
pbs.twimg.com/media/GJxqQWlX0AAWx91?format=jpg&name=med
lakers17 lakers17 16 minutes ago
Not in the OTC overall this year in my opinion. There will be selective winners but nothing remotely like 2021 where everything went up in the OTC. In early 2021 there was not one reporting trip play left. All were .001 or above. We will never see an OTC market like that again. Towards the end u
NWPN
vdt vdt 16 minutes ago
Good news for MTNB
"We project that the market for MAT2203 in the treatment of invasive aspergillosis in patients with limited treatment options could reach peak sales in the U.S. alone of over $400 million annually..."
MTNB
Pharma Sleuth Pharma Sleuth 19 minutes ago
Haven't really read it at this hour but it seems one is to provide employees stock options. That's awesome. Good for them. They are the ones actually doing the work.

And the other is paying Nasrat his shares he already worked for in lieu of salary

Cleaning up the over
ELTP
knrorrel knrorrel 19 minutes ago
thx , that's annoying, but if we reach 0.007 or more, then you'll have your 10Bagger too... just wait a few weeks and see how everything develops
imo

TMSH
Luckyyu Luckyyu 21 minutes ago
More from @runners_stock from x tonight!

If I’m a company merging into $LLBO I would feel better knowing I’m being sold a clean shell with no debt or court proceedings. Wouldn’t you? I feel that’s a good thing as Acropolis is taking all the right steps to get this current. We could wa
LLBO
Jaxxm Jaxxm 22 minutes ago
I guess you see so many great investors and volume it gave you confidence.. have a great weekend bud.
TMSH
knrorrel knrorrel 25 minutes ago
wow, thanks YOU that was a great post, I learned a lot of new great information and I think you are right with your experiences and you think that 2024 could also develop like 2021 ? (maybe I should start buying more trip stocks that want to run " violently " up ? TMS_H , IJJ_P , BDP_T ? and also
NWPN
1hot toddy 1hot toddy 27 minutes ago
u r going to get run over on monday and next week.
IGPK
1hot toddy 1hot toddy 30 minutes ago
lets get this to ten cents atleast here on otc and then they can do a 100/1
IGPK

Your Recent History

Delayed Upgrade Clock